Presented by Jennifer Mondillo, PhD, MBA, MSN, ANP-BC. Lunch will be provided. Attendees will be admitted on a first-come basis. This program explores the prevalence, impact, and symptoms of agitation associated with dementia due to Alzheimer’s disease, specifically focusing on patients living in a long-term care setting. Participants will review the current clinical care landscape for treatment of agitation associated with dementia due to Alzheimer’s disease. The program will also provide an overview of the Centers for Medicare & Medicaid Services Regulations on Antipsychotics. Supported by Otsuka America Pharmaceutical, Inc. and Lundbeck.